s/ico0.jpg) no-repeat -110px -170px;float:left;height:20px;color:#fff;Display:None;line-height:20px;font-size:12px;">

A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study

Full-Text HTML XML Download Download as PDF (Size:880KB) PP. 274-280
DOI: 10.4236/jct.2018.93025    484 Downloads   987 Views
Author(s)
Julie Taguchi, Christopher Duma, M. A. Nezami*

Affiliation(s)

Pacific Medical Center of Hope, Fresno, USA.

ABSTRACT

Concurrent dural and leptomeningeal metastatic carcinomatosis are very rare and have a poor prognosis. Here we present a woman with advanced estrogen receptor (ER) positive and progesterone receptor (PR) positive breast cancer who presented with leptomeningeal disease. Patient underwent multi targeted epigenetic therapies applied in a protocol called MTET. She continued to respond to the interval treatment, which consisted only of the nutraceutical agents. Here we discuss her case in detail and we believe that such an example might be applied to other patients in this situation resulting clinical improvement and less toxicity.

KEYWORDS

Breast Cancer, Metastatic, Leptomeningeal Disease, Dural Disease

Cite this paper

Taguchi, J. , Duma, C. and Nezami, M. (2018) A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study. Journal of Cancer Therapy, 9, 274-280. doi: 10.4236/jct.2018.93025.
JCT Subscription
E-Mail Alert
JCT Most popular papers
Publication Ethics & OA Statement
JCT News
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact Us

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.